Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-β/Smad signaling

Abstract

Members of the TGF-β family of growth factors signal from the cell surface through serine/threonine kinase receptors. Intracellular propagation of the signal occurs by phosphorylation of intracellular proteins of the Smad family. Smad7 belongs to the subclass of inhibitory Smads that function as antagonists of TGF-β signaling. A yeast two-hybrid screen of a human placental cDNA expression library using full-length mouse Smad7 as bait identified Yes-Associated Protein (YAP65) as a novel Smad7-interacting protein. The association of Smad7 with YAP65 was confirmed using co-expressed tagged proteins in COS-7 cells. Deletion of the PY motif of Smad7 reduced but did not abolish YAP65-Smad7 association, suggesting the existence of several interacting domains. We demonstrate that YAP65 potentiates the inhibitory activity of Smad7 against TGF-β-induced, Smad3/4-dependent, gene transactivation. Furthermore, YAP65 augments the association of Smad7 to activated TGF-β receptor type I (TβRI), whereas YAP65(1–301), which exerts a dominant-negative effect against Smad7-driven inhibition of TGF-β signaling, reduces these interactions. Together, these data provide the first evidence that YAP65 is a Smad7 partner that facilitates the recruitment of the latter to activated TβRI, and enhances the inhibitory activity of Smad7 against TGF-β signaling.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Attisano L, Wrana JL . 2000 Curr. Opin. Cell Biol. 12: 235–243

  • Branton MH, Kopp JB . 1999 Microbes Infect. 1: 1349–1365

  • Datta PK, Chytil A, Gorska AE, Moses HL . 1998 J. Biol. Chem. 273: 34671–34674

  • Datta PK, Moses HL . 2000 Mol. Cell. Biol. 20: 3157–3167

  • de Caestecker MP, Piek E, Roberts AB . 2000 J. Natl. Cancer Inst. 92: 1388–1402

  • Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM . 1998 EMBO J. 17: 3091–3100

  • Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K . 2001 J. Biol. Chem. 276: 12477–12480

  • Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Wrana JL . 2000 Mol. Cell. 6: 1365–1375

  • Lallemand F, Mazars A, Prunier C, Bertrand F, Kornprost M, Gallea S, Roman-Roman S, Cherqui G, Atfi A . 2001 Oncogene 20: 879–884

  • Landstrom M, Heldin NE, Bu S, Hermansson A, Itoh S, ten Dijke P, Heldin CH . 2000 Curr. Biol. 10: 535–538

  • Massagué J, Wotton D . 2000 EMBO J. 19: 1745–1754

  • Mazars A, Lallemand F, Prunier C, Marais J, Ferrand N, Pessah M, Cherqui G, Atfi A . 2001 J. Biol. Chem. 276: 36797–36803

  • Musacchio A, Wilmanns M, Saraste M . 1994 Prog. Biophys. Mol. Biol. 61: 283–297

  • Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, ten Dijke P . 1997 Nature 389: 631–635

  • Rotin D . 1998 Curr. Top. Microbiol. Immunol. 228: 115–133

  • Songyang Z, Fanning AS, Fu C, Xu J, Marfatia SM, Chishti AH, Crompton A, Chan AC, Anderson JM, Cantley LC . 1997 Science 275: 73–77

  • Sudol M . 1994 Oncogene 9: 2145–2152

  • Sudol M, Sliwa K, Russo T . 2001 FEBS Lett. 490: 190–195

  • Topper JN, Cai J, Qiu Y, Anderson KR, Xu YY, Deeds JD, Feeley R, Gimeno CJ, Woolf EA, Tayber O, Mays GG, Sampson BA, Schoen FJ, Gimbrone Jr MA, Falb D . 1997 Proc. Natl. Acad. Sci. USA 94: 9314–9319

  • Vojtek AB, Hollenberg SM, Cooper JA . 1993 Cell 74: 205–214

  • Wieser R, Wrana JL, Massagué J . 1995 EMBO J. 14: 2199–2208

  • Wrana JL . 2000 Cell 100: 189–192

  • Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y . 1999 EMBO J. 18: 2551–2562

Download references

Acknowledgements

We are indebted to Drs S Dennler, J-M Gauthier, Y Ito, K Miyazono, JN Topper and JL Wrana, who provided us with expression plasmids essential for this study. Supported by INSERM, CNRS, Association pour la Recherche contre le Cancer (ARC), Fondation de France, and Ligue Nationale Contre le Cancer (LNCC), France. O Ferrigno and F Lallemand are recipients of ARC and Fondation de France post-doctoral fellowships, respectively.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alain Mauviel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferrigno, O., Lallemand, F., Verrecchia, F. et al. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-β/Smad signaling. Oncogene 21, 4879–4884 (2002). https://doi.org/10.1038/sj.onc.1205623

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205623

Keywords

This article is cited by

Search

Quick links